Our Offerings
By Industry By Function
About Us
Our Viewpoint
NEW
 Senior Management Experts Panel Global Consultants Press Releases Blog
Infographics Market Insights Case Studies Illustrations In The Press
Contact Us
The Business Research Company Logo
Reports Store
Top 50 Healthcare Market Reports
NEW
 Top 50 Non-Healthcare Market Reports
NEW
 Opportunities And Strategies Reports Aerospace And Defense Agriculture Chemicals Construction
Electrical And Electronics Financial Services Food And Beverages Healthcare Services Hospitality Information Technology Machinery Media
Medical Equipment Metal And Mineral Mining Oil And Gas Paper, Plastics, Rubber, Wood And Textile Pharmaceuticals Professional Services Recreation
Retail And Wholesale Services Social Services Transport Transport Services Utilities Veterinary Healthcare Filter Reports by Trends
NEW
Market Intelligence Platform
About GMM Global Forecast
NEW
 Mega Trends Analysis
Consultancies Corporate Planning & Strategy Academic Financial Services Legal Services
Pricing Methodology Sources FAQ Press Coverage
Customized Research
Find Customers Optimise Your Marketing Mix Evaluate Competitors Identify Market Opportunities Develop Products And Services
Distributor And Partner Research Plan Finances Streamline Your Operations Devise Market Entry Strategy Explore Custom Research Packages
NEW
Continuous Research
Desk Research Research Reports Senior Executive Interviews Consumer Research Market Sizing And Forecasts
Company Information Analytics And Data Visualization Research Automation Web Crawling And Spidering AI-Empowered Research Services
Request Proposal
Roxadustat Global Market Report 2025
Request Sample Buy Now
Global Roxadustat Market Report 2025

Report Price : $4490.00

Pages : 175

Format : PDF

Published : March 2025

Delivery Time : 2-3 Business Days

Purchase This Report
Purchase This Report

Roxadustat Global Market Report 2025

By Type (20mg, 50mg), By Product Formulation (Oral Tablets), By Distribution Channel (Hospitals, Specialty Pharmacies, Dialysis Centers), By End-User Application (Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions) – Impact of Tariff and Trade War on Market Size, Growth, Trends, and Forecast 2025–2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Roxadustat Market Overview

• Roxadustat market size has reached to $6.44 billion in 2024

• Expected to grow to $8.95 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%

• Growth Driver: Impact Of Rising Chronic Kidney Disease Cases On The Growth Of The Market

• Market Trend: Roxadustat Reimbursement Under Ireland’s High Tech Drugs Scheme Accelerates Market Growth

• North America was the largest region in 2024 and Asia-Pacific is the fastest growing region.

What Is Covered Under Roxadustat Market?

Roxadustat is an orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) that stabilizes hypoxia-inducible factors, leading to increased erythropoietin production, enhanced iron absorption, and improved hemoglobin synthesis without the need for exogenous erythropoiesis-stimulating agents. It is used to manage anemia by addressing low hemoglobin levels in patients with chronic kidney disease and potentially other conditions involving impaired red blood cell production.

The main types in Roxadustat are 20 mg and 50 mg. 20 mg Roxadustat is an oral hypoxia-inducible factor-prolyl hydroxylase (HIF-PH) inhibitor used for treating anemia associated with chronic kidney disease by stimulating endogenous erythropoietin production. The product formulation of this is oral tablets, which are distributed by various channels such as hospitals, specialty pharmacies, and dialysis centers. Roxadustat is used in chronic kidney disease-associated anemia and others.

Roxadustat Market Size and growth rate 2025 to 2029: Graph

What Is The Roxadustat Market Size 2025 And Growth Rate?

The Roxadustat market size has grown strongly in recent years. It will grow from $6.44 billion in 2024 to $6.86 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to regulatory approvals in major markets, strong clinical trial results, increasing prevalence of chronic kidney disease, growing awareness of anemia management, and government support for anemia treatments.

What Is The Roxadustat Market Growth Forecast?

The Roxadustat market size is expected to see strong growth in the next few years. It will grow to $8.95 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to ongoing research for new indications, increasing healthcare expenditure, demand for non-injectable anemia treatments, expanding reimbursement policies, and rising geriatric population. Major trends in the forecast period include a shift towards oral anemia treatments, increasing competition from alternative therapies, expansion of licensing agreements, growing investment in hypoxia-inducible factor research, and a focus on patient-centric treatment approaches.

The forecast of 6.9% growth over the next five years reflects a modest reduction of 0.4% from the previous estimate for this market. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper U.S. dialysis patients by increasing the cost of HIF-PH inhibitors sourced from China and Germany, thereby reducing anemia management options and raising nephrology care expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us

What’s The Trade War Impact On Pharmaceuticals Industry?

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

How Is The Roxadustat Market Segmented?

1) By Type: 20mg, 50mg

2) By Product Formulation: Oral Tablets

3) By Distribution Channel: Hospitals, Specialty Pharmacies, Dialysis Centers

4) By End-User Application: Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions

Subsegments:

1) By 20mg: Oral Tablets, Injectable Formulations

2) By 50mg: Oral Tablets, Injectable Formulations

What Is Driving The Roxadustat Market? Impact Of Rising Chronic Kidney Disease Cases On The Growth Of The Market

The rising number of people with chronic kidney disease (CKD) is expected to propel the growth of the Roxadustat market going forward. Chronic kidney disease (CKD) is a long-term condition where the kidneys gradually lose their ability to function properly, often leading to kidney failure if left untreated. The number of people affected by chronic kidney disease is rising globally due to factors such as aging populations, increasing rates of diabetes, hypertension, and unhealthy lifestyles. Roxadustat helps manage chronic kidney disease by stimulating the production of erythropoietin, which increases red blood cell production and helps address anemia commonly associated with the condition, thereby improving overall kidney function and quality of life for patients. For instance, in December 2024, according to a report published by the Australian Institute of Health and Welfare (AIHW), an Australia-based government agency, the mortality rates for chronic kidney disease experienced a modest annual rise, increasing by 4.2% in 2021 and 6.2% in 2022. Therefore, the rising number of people with chronic kidney disease (CKD) is driving the growth of the Roxadustat industry.

Who Are The Major Players In The Global Roxadustat Market?

Major companies operating in the roxadustat market are AstraZeneca PLC, Viatris Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Hetero Drugs Limited, Akebia Therapeutics Inc., Metrochem API Private Limited, FibroGen Inc., AMI Lifesciences, Lee Pharma Ltd., Faran Shimi Pharmaceutical Company, Maithri Drugs Pvt. Ltd., Clearsynth Labs Ltd., Bal Pharma, HEMA Pharmaceuticals Pvt. Ltd., Zhejiang Hengkang Pharmaceutical Co. Ltd., Kimia Biosciences Pvt. Ltd., Lewens Labs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., GLR Innovations, Suzhou Biosyntech Co. Ltd., Shanvr Life Sciences Pvt. Ltd.

What Are The Key Trends Of The Global Roxadustat Market? Roxadustat Reimbursement Under Ireland’s High Tech Drugs Scheme Accelerates Market Growth

Major companies operating in the Roxadustat market are opting for reimbursement under the high-tech drugs scheme to ensure broader patient access by reducing financial barriers, thereby accelerating market uptake and demonstrating the cost-effectiveness of their innovative therapies. The high-tech drugs scheme is a government-managed program primarily in Ireland that provides reimbursement for the dispensing of expensive, highly specialized medications typically prescribed in hospital settings. For instance, in September 2022, Astellas Pharma Company Ltd., a US-based pharmaceutical company announced that its EVRENZO (Roxadustat) has been granted reimbursement under the High-Tech Drugs Scheme in Ireland. Roxadustat is the first in a new class of orally administered hypoxia-inducible factor prolyl hydroxylase (HIF PH) inhibitors licensed and reimbursed in Ireland. The results showed Roxadustat was effective in achieving and maintaining target hemoglobin levels (10-12g/dL) in patients with symptomatic anemia of CKD, regardless of dialysis status and prior ESA treatment.

Need data on a specific region in this market?
Request Customisation

What Are Latest Mergers And Acquisitions In The Roxadustat Market? Fibrogen Partners With Astellas Pharma And AstraZeneca For Roxadustat Development And Commercialization

In February 2024, FibroGen Inc., a US-based biopharmaceutical company, announced a partnership with Astellas Pharma Inc. and AstraZeneca PLC. With this collaboration, FibroGen Inc. aims to develop and commercialize Roxadustat for the treatment of anemia in various conditions, including chronic kidney disease (CKD) and myelodysplastic syndromes (MDS). Astellas Pharma Inc. is a Japan-based pharmaceutical company, and AstraZeneca PLC. is a UK-based pharmaceutical company involved in the development and commercialization of Roxadustat.

What Is The Regional Outlook For The Global Roxadustat Market?

North America was the largest region in the Roxadustat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Roxadustat Market?

The Roxadustat market consists of sales of products such as 70 mg, 100 mg, and 150 mg film-coated tablets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What is the Market Assessment and Strategic Outlook for the Roxadustat Industry?

The roxadustat market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the roxadustat industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Roxadustat Market Report Forecast Analysis

Report AttributeDetails
Market Size Value In 2025 $6.86 billion
Revenue Forecast In 2034 $8.95 billion
Growth Rate CAGR of 6.9% from 2025 to 2034
Base Year For Estimation 2024
Actual Estimates/Historical Data 2019-2024
Forecast Period 2025 - 2029 - 2034
Market Representation Revenue in USD Billion and CAGR from 2025 to 2034
Segments Covered The roxadustat market covered in this report is segmented –
1) By Type: 20mg, 50mg
2) By Product Formulation: Oral Tablets
3) By Distribution Channel: Hospitals, Specialty Pharmacies, Dialysis Centers
4) By End-User Application: Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions Subsegments:
1) By 20mg: Oral Tablets, Injectable Formulations
2) By 50mg: Oral Tablets, Injectable Formulations
Regional Scope Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain. Additional countries that can be covered in the report are Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled AstraZeneca PLC, Viatris Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Hetero Drugs Limited, Akebia Therapeutics Inc., Metrochem API Private Limited, FibroGen Inc., AMI Lifesciences, Lee Pharma Ltd., Faran Shimi Pharmaceutical Company, Maithri Drugs Pvt. Ltd., Clearsynth Labs Ltd., Bal Pharma, HEMA Pharmaceuticals Pvt. Ltd., Zhejiang Hengkang Pharmaceutical Co. Ltd., Kimia Biosciences Pvt. Ltd., Lewens Labs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., GLR Innovations, Suzhou Biosyntech Co. Ltd., Shanvr Life Sciences Pvt. Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

Table Of Contents

1. Executive Summary

2. Roxadustat Market Characteristics

3. Roxadustat Market Trends And Strategies

4. Roxadustat Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Roxadustat Growth Analysis And Strategic Analysis Framework

5.1. Global Roxadustat PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

5.2. Analysis Of End Use Industries

5.3. Global Roxadustat Market Growth Rate Analysis

5.4. Global Roxadustat Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)

5.5. Global Roxadustat Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)

5.6. Global Roxadustat Total Addressable Market (TAM)

6. Roxadustat Market Segmentation

6.1. Global Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20mg

50mg

6.2. Global Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Oral Tablets

6.3. Global Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Hospitals

Specialty Pharmacies

Dialysis Centers

6.4. Global Roxadustat Market, Segmentation By End-User Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

Chronic Kidney Disease-Associated Anemia

Other Anemia Conditions

7. Roxadustat Market Regional And Country Analysis

7.1. Global Roxadustat Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

7.2. Global Roxadustat Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Roxadustat Market

8.1. Asia-Pacific Roxadustat Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

8.2. Asia-Pacific Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.3. Asia-Pacific Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8.4. Asia-Pacific Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Roxadustat Market

9.1. China Roxadustat Market Overview

9.2. China Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.3. China Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

9.4. China Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Roxadustat Market

10.1. India Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.2. India Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

10.3. India Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Roxadustat Market

11.1. Japan Roxadustat Market Overview

11.2. Japan Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.3. Japan Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11.4. Japan Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Roxadustat Market

12.1. Australia Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.2. Australia Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12.3. Australia Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Roxadustat Market

13.1. Indonesia Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.2. Indonesia Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13.3. Indonesia Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Roxadustat Market

14.1. South Korea Roxadustat Market Overview

14.2. South Korea Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.3. South Korea Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14.4. South Korea Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Roxadustat Market

15.1. Western Europe Roxadustat Market Overview

15.2. Western Europe Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.3. Western Europe Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15.4. Western Europe Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Roxadustat Market

16.1. UK Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.2. UK Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16.3. UK Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Roxadustat Market

17.1. Germany Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.2. Germany Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17.3. Germany Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Roxadustat Market

18.1. France Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.2. France Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18.3. France Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Roxadustat Market

19.1. Italy Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.2. Italy Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19.3. Italy Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Roxadustat Market

20.1. Spain Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.2. Spain Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20.3. Spain Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Roxadustat Market

21.1. Eastern Europe Roxadustat Market Overview

21.2. Eastern Europe Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.3. Eastern Europe Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21.4. Eastern Europe Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Roxadustat Market

22.1. Russia Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.2. Russia Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22.3. Russia Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Roxadustat Market

23.1. North America Roxadustat Market Overview

23.2. North America Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.3. North America Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23.4. North America Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Roxadustat Market

24.1. USA Roxadustat Market Overview

24.2. USA Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.3. USA Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24.4. USA Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Roxadustat Market

25.1. Canada Roxadustat Market Overview

25.2. Canada Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.3. Canada Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25.4. Canada Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Roxadustat Market

26.1. South America Roxadustat Market Overview

26.2. South America Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.3. South America Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26.4. South America Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Roxadustat Market

27.1. Brazil Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.2. Brazil Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27.3. Brazil Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Roxadustat Market

28.1. Middle East Roxadustat Market Overview

28.2. Middle East Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.3. Middle East Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28.4. Middle East Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Roxadustat Market

29.1. Africa Roxadustat Market Overview

29.2. Africa Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.3. Africa Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29.4. Africa Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Roxadustat Market Competitive Landscape And Company Profiles

30.1. Roxadustat Market Competitive Landscape

30.2. Roxadustat Market Company Profiles

30.2.1. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis

30.2.2. Viatris Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.3. Astellas Pharma Inc. Overview, Products and Services, Strategy and Financial Analysis

30.2.4. Dr. Reddy's Laboratories Ltd. Overview, Products and Services, Strategy and Financial Analysis

30.2.5. Hetero Drugs Limited Overview, Products and Services, Strategy and Financial Analysis

31. Roxadustat Market Other Major And Innovative Companies

31.1. Akebia Therapeutics Inc.

31.2. Metrochem API Private Limited

31.3. FibroGen Inc.

31.4. AMI Lifesciences

31.5. Lee Pharma Ltd.

31.6. Faran Shimi Pharmaceutical Company

31.7. Maithri Drugs Pvt. Ltd.

31.8. Clearsynth Labs Ltd.

31.9. Bal Pharma

31.10. HEMA Pharmaceuticals Pvt. Ltd.

31.11. Zhejiang Hengkang Pharmaceutical Co. Ltd.

31.12. Kimia Biosciences Pvt. Ltd.

31.13. Lewens Labs Pvt. Ltd.

31.14. Hangzhou Longshine Bio-Tech Co. Ltd.

31.15. GLR Innovations

32. Global Roxadustat Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Roxadustat Market

34. Recent Developments In The Roxadustat Market

35. Roxadustat Market High Potential Countries, Segments and Strategies

35.1 Roxadustat Market In 2029 - Countries Offering Most New Opportunities

35.2 Roxadustat Market In 2029 - Segments Offering Most New Opportunities

35.3 Roxadustat Market In 2029 - Growth Strategies

35.3.1 Market Trend Based Strategies

35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations

36.2. Currencies

36.3. Historic And Forecast Inflation Rates

36.4. Research Inquiries

36.5. The Business Research Company

36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Table 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Table 3: Global Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 4: Global Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 5: Global Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 6: Global Roxadustat Market, Segmentation By End-User Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 7: Global Roxadustat Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 8: Global Roxadustat Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 9: Asia-Pacific, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 10: Asia-Pacific, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 11: Asia-Pacific, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 12: China, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 13: China, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 14: China, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 15: India, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 16: India, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 17: India, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 18: Japan, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 19: Japan, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 20: Japan, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 21: Australia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 22: Australia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 23: Australia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 24: Indonesia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 25: Indonesia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 26: Indonesia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 27: South Korea, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 28: South Korea, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 29: South Korea, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 30: Western Europe, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 31: Western Europe, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 32: Western Europe, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 33: UK, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 34: UK, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 35: UK, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 36: Germany, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 37: Germany, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 38: Germany, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 39: France, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 40: France, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 41: France, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 42: Italy, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 43: Italy, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 44: Italy, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 45: Spain, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 46: Spain, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 47: Spain, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 48: Eastern Europe, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 49: Eastern Europe, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 50: Eastern Europe, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 51: Russia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 52: Russia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 53: Russia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 54: North America, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 55: North America, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 56: North America, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 57: USA, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 58: USA, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 59: USA, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 60: Canada, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 61: Canada, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 62: Canada, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 63: South America, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 64: South America, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 65: South America, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 66: Brazil, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 67: Brazil, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 68: Brazil, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 69: Middle East, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 70: Middle East, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 71: Middle East, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 72: Africa, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 73: Africa, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 74: Africa, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Table 75: AstraZeneca PLC Financial Performance
  • Table 76: Viatris Inc. Financial Performance
  • Table 77: Astellas Pharma Inc. Financial Performance
  • Table 78: Dr. Reddy's Laboratories Ltd. Financial Performance
  • Table 79: Hetero Drugs Limited Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2019-2024, $ Billion
  • Figure 2: Global Forecast Market Growth, 2024-2029F, 2034F, $ Billion
  • Figure 3: Global Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 4: Global Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 5: Global Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 6: Global Roxadustat Market, Segmentation By End-User Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 7: Global Roxadustat Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 8: Global Roxadustat Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 9: Asia-Pacific, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 10: Asia-Pacific, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 11: Asia-Pacific, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 12: China, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 13: China, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 14: China, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 15: India, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 16: India, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 17: India, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 18: Japan, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 19: Japan, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 20: Japan, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 21: Australia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 22: Australia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 23: Australia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 24: Indonesia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 25: Indonesia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 26: Indonesia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 27: South Korea, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 28: South Korea, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 29: South Korea, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 30: Western Europe, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 31: Western Europe, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 32: Western Europe, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 33: UK, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 34: UK, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 35: UK, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 36: Germany, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 37: Germany, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 38: Germany, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 39: France, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 40: France, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 41: France, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 42: Italy, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 43: Italy, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 44: Italy, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 45: Spain, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 46: Spain, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 47: Spain, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 48: Eastern Europe, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 49: Eastern Europe, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 50: Eastern Europe, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 51: Russia, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 52: Russia, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 53: Russia, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 54: North America, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 55: North America, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 56: North America, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 57: USA, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 58: USA, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 59: USA, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 60: Canada, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 61: Canada, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 62: Canada, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 63: South America, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 64: South America, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 65: South America, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 66: Brazil, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 67: Brazil, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 68: Brazil, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 69: Middle East, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 70: Middle East, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 71: Middle East, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 72: Africa, Roxadustat Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 73: Africa, Roxadustat Market, Segmentation By Product Formulation, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 74: Africa, Roxadustat Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Figure 75: AstraZeneca PLC Financial Performance
  • Figure 76: Viatris Inc. Financial Performance
  • Figure 77: Astellas Pharma Inc. Financial Performance
  • Figure 78: Dr. Reddy's Laboratories Ltd. Financial Performance
  • Figure 79: Hetero Drugs Limited Financial Performance

Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Read More About Strategic Growth Drivers Shaping the Nutraceutical Excipients Market Outlook 2025- 2034:The Role Of Health And Wellness In Driving Growth In The Nutraceutical Excipients Market

Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Read More About Emerging Growth Drivers in the Opioids Market Landscape: Growing Surgical Procedures Fueling Demand In The Opioids Market

Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Read More About Osimertinib Drugs Market Outlook 2025–2034: Identifying Growth Drivers, Technology Trends, and Policy Impact

Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

Read More About Otic Drugs Market Insights: In-Depth Look at Growth Trends, Market Size, and Opportunities for 2025-2034

A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

Read More About A 2025 analysis offering size estimates, growth trends and technological innovations in the live cell imaging microscopes market.

A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

Read More About A 2025 market overview covering growth forecasts, treatment landscape, and key stakeholders in the isovaleric acidemia treatment market.

A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

Read More About A dynamic 2025 report outlining growth drivers, pipeline innovations, and key markets in liver cancer therapeutics.

A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Read More About A 2025 analysis tracking API pricing, competitive landscape, and growth strategies in the losartan potassium active pharmaceutical ingredient market.

Hardware Support Services Market 2022 – By Type (Networking Support Services, Storage And Servers Support Services, Computer And Peripherals Support Services, Other Hardware Support Services), By Mode (Offline, Online), ...

View Report

Premium Cosmetics Global Market Report 2025 – By Product Type (Skin Care, Hair Care, Fragrances and Perfumes, Sun Care, Baby Care, Other Product Types), By Nature (Natural and Organic, Conventional), By Gender (Male, Fem...

View Report

Chromatography Software Global Market Report 2025 – By Software Type (Standalone Software, Integrated Software), By Deployment (Web Based, On-Premises, Cloud Based), By Version (Normal, Customized), By Application (Pharm...

View Report

Vermiculite Global Market Report 2025 – By Type (Large Grade Vermiculite, Fine And Finer Grade Vermiculite, Medium Grade Vermiculite), By Product (Crude Vermiculite, Exfoliated Vermiculite), By End-User Industry (Chemica...

View Report

Electric Vehicle Communication Controller Global Market Report 2025 – By System (Vehicle-based Communication Controller, Supply Equipment Communication Controlled), By Charging Type (Wired Charging, Wireless Charging), B...

View Report

Used Truck Global Market Report 2025 – By Type (Light-Duty Truck, Medium-Duty Truck, Heavy-Duty Truck), By Fuel Type (Gasoline, Electric, Diesel), By Sales Channel (Franchised Dealer, Independent Dealer, Peer-To-Peer), B...

View Report

Augmented Industrial Reality Global Market Report 2025 – By Component (Hardware, Software, Services), By Technology (Marker Based AR Technology, Marker Less AR Technology, Anchor Based AR Technology), By Application (Pro...

View Report

Frequently Asked Questions

Roxadustat is an orally administered hypoxia-inducible factor prolyl hydroxylase inhibitor (HIF-PHI) that stabilizes hypoxia-inducible factors, leading to increased erythropoietin production, enhanced iron absorption, and improved hemoglobin synthesis without the need for exogenous erythropoiesis-stimulating agents. It is used to manage anemia by addressing low hemoglobin levels in patients with chronic kidney disease and potentially other conditions involving impaired red blood cell production. For further insights on this market, request a sample here

The market major growth driver - Impact Of Rising Chronic Kidney Disease Cases On The Growth Of The Market. For further insights on this market, request a sample here

The roxadustat market size has grown strongly in recent years. It will grow from $6.44 billion in 2024 to $6.86 billion in 2025 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to regulatory approvals in major markets, strong clinical trial results, increasing prevalence of chronic kidney disease, growing awareness of anemia management, and government support for anemia treatments. The roxadustat market size is expected to see strong growth in the next few years. It will grow to " $8.95 billion in 2029 at a compound annual growth rate (CAGR) of 6.9%. The growth in the forecast period can be attributed to ongoing research for new indications, increasing healthcare expenditure, demand for non-injectable anemia treatments, expanding reimbursement policies, and rising geriatric population. Major trends in the forecast period include a shift towards oral anemia treatments, increasing competition from alternative therapies, expansion of licensing agreements, growing investment in hypoxia-inducible factor research, and a focus on patient-centric treatment approaches. For further insights on this market, request a sample here

The roxadustat market covered in this report is segmented –
1) By Type: 20mg, 50mg
2) By Product Formulation: Oral Tablets
3) By Distribution Channel: Hospitals, Specialty Pharmacies, Dialysis Centers
4) By End-User Application: Chronic Kidney Disease-Associated Anemia, Other Anemia Conditions For further insights on this market, request a sample here

North America was the largest region in the Roxadustat market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the roxadustat market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on this market, request a sample here.

Major companies operating in the roxadustat market are AstraZeneca PLC, Viatris Inc., Astellas Pharma Inc., Dr. Reddy's Laboratories Ltd., Hetero Drugs Limited, Akebia Therapeutics Inc., Metrochem API Private Limited, FibroGen Inc., AMI Lifesciences, Lee Pharma Ltd., Faran Shimi Pharmaceutical Company, Maithri Drugs Pvt. Ltd., Clearsynth Labs Ltd., Bal Pharma, HEMA Pharmaceuticals Pvt. Ltd., Zhejiang Hengkang Pharmaceutical Co. Ltd., Kimia Biosciences Pvt. Ltd., Lewens Labs Pvt. Ltd., Hangzhou Longshine Bio-Tech Co. Ltd., GLR Innovations, Suzhou Biosyntech Co. Ltd., Shanvr Life Sciences Pvt. Ltd. . For further insights on this market, request a sample here.

Major trends in this market include Roxadustat Reimbursement Under Ireland’s High Tech Drugs Scheme Accelerates Market Growth. For further insights on this market, request a sample here.

Customer representative image Book your 30 minutes free consultation with our research experts
Contact Us
Global Roxadustat Market Report 2025

Wait, we have a special offer for you! ✋

Get your exclusive 20% discount only on the Global Market Reports now using the code ONLINE20*

YES, get the discount! No, I'd pay the full price

*Copy paste the discount code in the cart

Back to top WhatsApp icon